Susquehanna Trust & Investment’s AbbVie ABBV Stock Holding History

Susquehanna Trust & Investment’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$444K	Sell	6,612 -750	-10%	-$49K	0.1%	82
2015 Q1	$431K	Hold	7,362	–	–	0.09%	76
2014 Q4	$482K	Sell	7,362 -310	-4%	-$19.5K	0.1%	76
2014 Q3	$443K	Buy	7,672 +450	+6%	+$25K	0.1%	74
2014 Q2	$408K	Sell	7,222 -495	-6%	-$26K	0.09%	71
2014 Q1	$397K	Sell	7,717 -104	-1%	-$5.26K	0.09%	74
2013 Q4	$413K	Sell	7,821 -321	-4%	-$15.8K	0.09%	72
2013 Q3	$364K	Sell	8,142 -199	-2%	-$8.82K	0.08%	67
2013 Q2	$345K	Buy	+8,341	New	+$365K	0.08%	65

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Susquehanna Trust & Investment's ABBV Position: Q2 2015 in Review

Susquehanna Trust & Investment reduced its AbbVie (ABBV) stake by 10% in Q2 2015, selling an estimated $49K and leaving 6,612 shares worth $444K. The position accounts for 0.1% of the portfolio, ranked #82.

Susquehanna Trust & Investment first reported a position in ABBV in Q2 2013 and has held it in 9 quarters since. The position peaked at $482K in Q4 2014. 1,652 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

Susquehanna Trust & Investment held 6,612 shares of AbbVie worth $444K as of Q2 2015.
Susquehanna Trust & Investment sold 750 AbbVie shares in Q2 2015, an estimated $49K.
AbbVie made up 0.1% of Susquehanna Trust & Investment's portfolio in Q2 2015, its #82 holding.
Susquehanna Trust & Investment first reported a position in AbbVie in Q2 2013 and has held it in 9 quarters since.
Susquehanna Trust & Investment's AbbVie position peaked at $482K in Q4 2014.
1,652 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Susquehanna Trust & Investment's 13F filing for Q2 2015, filed 24 Jul 2015.